Surrozen (SRZN) Earnings Date & Reports

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SRZN is expected to report earnings to fall 66.01% to -293 cents per share on March 21

Q4'23

Est.

$-2.93

Q4'24

Missed

by $5.92

Q3'23

Missed

by $0.04

Q2'23

Missed

by $4.24

Q1'23

Missed

by $6.85

The last earnings report on March 31 showed earnings per share of -861 cents, missing the estimate of -270 cents. With 19.57K shares outstanding, the current market capitalization sits at 70.93M.

View a ticker or compare two or three

Compare

SRZN